Orca Capital holds 8.4% of Jupiter Neurosciences

JUPITER NEUROSCIENCES, INC.

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. (JUNS) is the issuer of common stock referenced in this Schedule 13G. Orca Capital, a German entity, reported beneficial ownership of 102,564 shares of Jupiter Neurosciences common stock, par value $0.0001 per share.

This position represents 8.4% of the outstanding common stock, based on 1,220,601 shares outstanding immediately after the completion of the issuer's registered offering described in a Prospectus Supplement filed under Rule 424(b)(5) on August 24, 2026. Orca Capital reports sole voting and dispositive power over all 102,564 shares and no shared power. The Schedule 13G is signed by Thomas Konig as Director of Orca Capital.

Key Figures

Shares beneficially owned: 102,564 shares of common stock Percent of class: 8.4% Shares outstanding: 1,220,601 shares +3 more

6 metrics

Shares beneficially owned 102,564 shares of common stock Beneficially owned by Orca Capital as reported in Item 4(a)

Percent of class 8.4% Orca Capital’s reported ownership percentage of Jupiter Neurosciences common stock

Shares outstanding 1,220,601 shares Common stock outstanding immediately after completion of the issuer’s registered offering

Sole voting power 102,564 shares Shares over which Orca Capital has sole power to vote or direct the vote

Shared voting power 0 shares Shares over which Orca Capital has shared power to vote or direct the vote

Sole dispositive power 102,564 shares Shares over which Orca Capital has sole power to dispose or direct the disposition

Key Terms

beneficially owned, Sole Voting Power, Percent of class, Prospectus Supplement, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 102,564"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Sole Voting Power 102,564.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Percent of class financial

"Percent of class: 8.4%"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

Prospectus Supplement regulatory

"Issuer's Prospectus Supplement filed pursuant to Rule 424(b)(5)"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Rule 424(b)(5) regulatory

"Prospectus Supplement filed pursuant to Rule 424(b)(5)"

FAQ

What stake in JUNS does Orca Capital report in this Schedule 13G?

Orca Capital reports beneficial ownership of 102,564 shares of Jupiter Neurosciences, Inc. common stock. This represents 8.4% of the class, calculated using 1,220,601 shares outstanding immediately after the company’s registered offering described in its August 24, 2026 Prospectus Supplement.

How much of JUNS’s outstanding stock is used to calculate Orca Capital’s 8.4% ownership?

The 8.4% ownership is calculated based on an aggregate of 1,220,601 shares of Jupiter Neurosciences common stock outstanding immediately after completion of the issuer’s registered offering described in a Prospectus Supplement filed under Rule 424(b)(5) on August 24, 2026.

Does Orca Capital have sole or shared voting power over its JUNS shares?

Orca Capital reports sole voting power over 102,564 shares and shared voting power over 0 shares of Jupiter Neurosciences common stock. It also reports sole dispositive power over the same 102,564 shares and no shared dispositive power.

Who signed the Schedule 13G for Orca Capital related to JUNS?

The Schedule 13G for Jupiter Neurosciences, Inc. was signed by Thomas Konig, identified as a Director of Orca Capital. The signature block shows the signature “/s/ Thomas Konig” with his title and a date of August 28, 2026.

What class of JUNS securities is covered by this Schedule 13G filing?

The filing covers Jupiter Neurosciences, Inc. Common Stock, par value $0.0001 per share. The CUSIP number listed for this class of securities is 48208B302, and Orca Capital’s reported holdings and percentage relate to this common stock class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 05:00 PM Accepted by SEC EDGAR 08/28/2026 - 04:59 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Jupiter Neurosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

48208B302

(CUSIP Number)

08/21/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 48208B302

1

Names of Reporting Persons

Orca Capital AG

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

GERMANY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 102,564.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 102,564.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

102,564.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.4 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: All ownership percentages set forth in this Schedule 13G are calculated based upon an aggregate of 1,220,601 shares of common stock outstanding immediately after giving effect to the completion of the Issuer's registered offering as provided in the Issuer's Prospectus Supplement filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on August 24, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Jupiter Neurosciences, Inc.
(b)	Address of issuer's principal executive offices: 1001 North US Hwy 1, Suite 504, Jupiter, Florida 33477
Item 2.
(a)	Name of person filing: Orca Capital AG
(b)	Address or principal business office or, if none, residence: Sperlring 2 85276 Hettenshausen Deutschland
(c)	Citizenship: Germany
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 48208B302
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 102,564
(b)	Percent of class: 8.4%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 102,564
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 102,564
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Orca Capital AG

Signature:	/s/ Thomas Konig
Name/Title:	Thomas Konig/Director
Date:	08/28/2026